Garenoxacin (BMS-284756) and Moxifloxacin in Experimental Meningitis Caused by Vancomycin-Tolerant Pneumococci

The emergence of multidrug-resistant strains of Streptococcus pneumoniae drives the development and evaluation of new antipneumococcal agents, especially for the treatment of bacterial meningitis. The aims of the present study were to assess the antibacterial effectiveness of two new quinolones, gar...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Rodriguez-Cerrato, Violeta, McCoig, Cindy C., Saavedra, Jesus, Barton, Tess, Michelow, Ian C., Hardy, Robert D., Bowlware, Karen, Iglehart, Janie, Katz, Kathy, McCracken, George H.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2003
Soggetti:
Experimental Therapeutics
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC148949/
https://ncbi.nlm.nih.gov/pubmed/12499193
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.47.1.211-215.2003
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi